Theravance Biopharma Inc - Enterprise Value

The Enterprise Value as of July 2026 (TTM) for Theravance Biopharma Inc (TBPH) is 658.50M

According to Theravance Biopharma Inc’s latest financial reports and current stock price. The company's current Enterprise Value is 658.50M. This represents a change of 9.65% compared to the average of 600.57M of the last 4 quarters.

Theravance Biopharma Inc (TBPH) Historical Enterprise Value (quarterly & annually)

How has TBPH Enterprise Value performed in the past?

The mean historical Enterprise Value of Theravance Biopharma Inc over the last ten years is 1.18B. The current 658.50M Enterprise Value has changed 5.47% with respect to the historical average. Over the past ten years (40 quarters), TBPH's Enterprise Value was at its highest in in the June 2017 quarter at 2.17B. The Enterprise Value was at its lowest in in the June 2025 quarter at 317.98M.

Theravance Biopharma Inc (TBPH) Enterprise Value by Quarter and Year

Discovering the peaks and valleys of Theravance Biopharma Inc Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Theravance Biopharma Inc (TBPH) Average Enterprise Value

How has TBPH Enterprise Value performed in the past?

The current Enterprise Value of Theravance Biopharma Inc (TBPH) is greater than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

Theravance Biopharma Inc (TBPH) Enterprise Value vs. Peers

How is TBPH’s Enterprise Value compared to its peers?

Theravance Biopharma Inc’s Enterprise Value is less than BlackRock Innovation and Growth Term Trust (894.72M), less than Monte Rosa Therapeutics, Inc. (1.70B), less than Day One Biopharmaceuticals, Inc. (2.03B), less than Geron Corporation (1.08B), greater than Replimune Group, Inc. (356.71M), less than Vir Biotechnology, Inc. (1.28B), greater than LENZ Therapeutics, Inc. (155.25M), less than ArriVent BioPharma, Inc. (1.34B), greater than Valneva SE (522.41M), less than Tyra Biosciences, Inc. (1.77B),

Build a custom stock screener for Theravance Biopharma Inc (TBPH) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Theravance Biopharma Inc using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Theravance Biopharma Inc (TBPH) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Theravance Biopharma Inc or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.